T2DM: Type 2 Diabetes Mellitus
Diabetes Obes Metab 25:19321941 Knop FK, Aroda VR, Do Vale RD et al (2023) Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Make sure to order your new prescription in time so you do not miss your next dose
The isobologram curves were constructed by plotting FIC tam vs FIC rotenone
Tirzepatide Results: What to Expect Average weight loss of 20-22% of total body weight over 72 weeks Significant improvements in A1c, blood pressure, lipid panels, and inflammatory markers Many patients lose 30-50+ pounds within the first 6-9 months Sustained results with proper maintenance protocols Individual results vary based on starting weight, adherence, lifestyle factors, and dosing
Its essential to have a healthcare professional evaluate your health history, weight loss goals, and any underlying conditions to ensure this combination is safe for you